Discontinued — last reported Q4 '23

Business Segments · Restructuring Reserve

CarelonRx Segment — Restructuring Reserve

This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2021
Last reportedQ4 2023

How to read this metric

A growing reserve indicates planned future organizational changes, while a shrinking reserve suggests the completion of restructuring actions.

Detailed definition

This represents the liability balance set aside for future cash outflows related to planned restructuring activities wit...

Peer comparison

Standard accounting practice for companies undergoing significant organizational shifts, often found in 'Restructuring' footnotes.

Metric ID: elv_segment_carelonrx_segment_restructuring_reserve

Historical Data

4 periods
 Q4 '21Q4 '22Q3 '23Q4 '23
Value$1.00M$1.00M$0.00$0.00
QoQ Change+0.0%-100.0%
YoY Change+0.0%-100.0%
Range$0.00$1.00M
Avg YoY Growth-50.0%
Median YoY Growth-50.0%
Current Streak2 quarters decline

Frequently Asked Questions

What is Elevance Health's carelonrx segment — restructuring reserve?
Elevance Health (ELV) reported carelonrx segment — restructuring reserve of $0.00 in Q4 2023.
What does carelonrx segment — restructuring reserve mean?
The amount of money set aside to cover future costs of reorganizing the pharmacy services business.